E-LIB Suche - Ergebnisse für: Van de Wiele, Victor - Sprache DE

Artikel (Online) X

Personensuche X

Sortierung: Relevanz

Sortierung: Jahr

1

Biologic patent challenges under the America Invents Act:

Van de Wiele, Victor L. ; Kesselheim, Aaron S. ; Tu, S. Sean
Nature Biotechnology. 42 (2024) 3 - p. 374-377 , 2024

Link: https://doi.org/10.1038/..

2

Measuring and Understanding Market Exclusivity Length for N..:

Van de Wiele, Victor L. ; Kesselheim, Aaron S. ; Gleeson, Deborah...
Pharmaceutical Medicine. , 2024

Link: https://doi.org/10.1007/..

3

The prevalence of drug patent term extensions in the United..:

Van de Wiele, Victor L. ; Kesselheim, Aaron S. ; Nagar, Sarosh.
Nature Biotechnology. 41 (2023) 7 - p. 903-906 , 2023

Link: https://doi.org/10.1038/..

4

An Empirical Review of Key Glucose Monitoring Devices: Prod..:

Darrow, Jonathan J. ; Van de Wiele, Victor ; Beran, David.
Journal of Diabetes Science and Technology. , 2023

Link: https://doi.org/10.1177/..

5

Transferable Exclusivity Vouchers and Incentives for Antimi..:

Van de Wiele, Victor L. ; Raymakers, Adam ; Kesselheim, Aaron S..
Journal of Law, Medicine & Ethics. 51 (2023) 1 - p. 213-216 , 2023

Link: https://doi.org/10.1017/..

6

Competition law and pricing among biologic drugs: the case ..:

Van de Wiele, Victor L ; Hammer, Maximilian ; Parikh, Ravi...
Journal of Law and the Biosciences. 9 (2022) 1 - p. , 2022

Link: https://doi.org/10.1093/..

7

The characteristics of patents impacting availability of bi..:

Van de Wiele, Victor L. ; Beall, Reed F. ; Kesselheim, Aaron S..
Nature Biotechnology. 40 (2022) 1 - p. 22-25 , 2022

Link: https://doi.org/10.1038/..

8

Regulatory Agency Transparency for Drugs and Biologics: A C..:

Huneycutt, Brenda J. ; Malkin, Brian J. ; Van de Wiele, Victor..
Food and Drug Law Journal. 75 (2020) 4 - p. 498-551 , 2020

Link: https://www.jstor.org/st..

1-8